PEREGRINE PHARMACEUTICALS IN's ticker is and the CUSIP is 713661954. A total of 2 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $26,000 | -27.8% | 22,600 | -35.1% | 0.00% | – |
Q3 2015 | $36,000 | +56.5% | 34,800 | +96.6% | 0.00% | – |
Q2 2015 | $23,000 | +27.8% | 17,700 | +31.1% | 0.00% | – |
Q1 2015 | $18,000 | -56.1% | 13,500 | -54.1% | 0.00% | -100.0% |
Q4 2014 | $41,000 | -55.4% | 29,400 | -56.7% | 0.00% | 0.0% |
Q3 2014 | $92,000 | -45.2% | 67,900 | -24.0% | 0.00% | -66.7% |
Q2 2014 | $168,000 | -10.6% | 89,400 | -9.7% | 0.00% | 0.0% |
Q1 2014 | $188,000 | +42.4% | 99,000 | +4.5% | 0.00% | +50.0% |
Q4 2013 | $132,000 | -51.6% | 94,700 | -51.1% | 0.00% | -60.0% |
Q3 2013 | $273,000 | +54.2% | 193,600 | +41.2% | 0.01% | +25.0% |
Q2 2013 | $177,000 | – | 137,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 94,700 | $132,000 | 0.00% |
Citadel Advisors | 900 | $1,000 | 0.00% |